StockOtters
StockOttersSupply Chain Map

BioNTech SE

BNTX

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
2,751
Cost of Revenue
541
Gross Profit
2,210
Gross Margin
80.3%
Operating Income
-1,314
Operating Margin
-47.8%
Net Income
-665
Net Margin
-24.2%
EPS (Basic)
$-2.77
EPS (Diluted)
$-2.77
EBITDA
-367
EBITDA Margin
-13.3%

2023

12/31/2023

Revenue
3,819
Cost of Revenue
600
Gross Profit
3,219
Gross Margin
84.3%
Operating Income
690
Operating Margin
18.1%
Net Income
930
Net Margin
24.4%
EPS (Basic)
$3.87
EPS (Diluted)
$3.83
EBITDA
1,088
EBITDA Margin
28.5%

2022

12/31/2022

Revenue
17,311
Cost of Revenue
4,532
Gross Profit
12,779
Gross Margin
73.8%
Operating Income
12,643
Operating Margin
73.0%
Net Income
9,434
Net Margin
54.5%
EPS (Basic)
$38.08
EPS (Diluted)
$37.09
EBITDA
12,858
EBITDA Margin
74.3%

2021

12/31/2021

Revenue
18,977
Cost of Revenue
3,861
Gross Profit
15,116
Gross Margin
79.7%
Operating Income
15,284
Operating Margin
80.5%
Net Income
10,293
Net Margin
54.2%
EPS (Basic)
$43.87
EPS (Diluted)
$41.21
EBITDA
15,730
EBITDA Margin
82.9%

2020

12/31/2020

Revenue
482
Cost of Revenue
704
Gross Profit
-222
Gross Margin
-46.0%
Operating Income
-82
Operating Margin
-17.1%
Net Income
15
Net Margin
3.2%
EPS (Basic)
$0.06
EPS (Diluted)
$0.06
EBITDA
-98
EBITDA Margin
-20.3%